PubMed

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S.

Ann Intern Med. 2001 Apr 17;134(8):629-36.PMID: 11304102 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiovascular risk in patients with mild renal insufficiency: implications for the use of ACE inhibitors.

Mann JF.

Presse Med. 2005 Oct 22;34(18):1303-8. Review.PMID: 16269994 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Trial of a drug to decrease the risk for heart disease in patients with mild kidney failure.

[No authors listed]

Ann Intern Med. 2001 Apr 17;134(8):S-96. No abstract available. PMID: 11324633 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G.

N Engl J Med. 2000 Jan 20;342(3):145-53. Erratum in: 2000 May 4;342(18):1376. N Engl J Med 2000 Mar 9;342(10):748. PMID: 10639539 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors.

Mann JF, Gerstein HC, Pogue J, Lonn E, Yusuf S.

Am J Cardiovasc Drugs. 2002;2(3):157-62. Review.PMID: 14727978 [PubMed - indexed for MEDLINE]Related articles

Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?

Ahmed A.

J Am Geriatr Soc. 2002 Jul;50(7):1297-300.PMID: 12133029 [PubMed - indexed for MEDLINE]Related articles

Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study.

Mann JF, Gerstein HC, Yi QL, Franke J, Lonn EM, Hoogwerf BJ, Rashkow A, Yusuf S; HOPE Investigators.

Am J Kidney Dis. 2003 Nov;42(5):936-42.PMID: 14582037 [PubMed - indexed for MEDLINE]Related articles

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).

Marre M, Lievre M, Chatellier G, Mann JF, Passa P, Ménard J; DIABHYCAR Study Investigators.

BMJ. 2004 Feb 28;328(7438):495. Epub 2004 Feb 11. Erratum in: BMJ. 2004 Mar 20;328(7441):686. PMID: 14960504 [PubMed - indexed for MEDLINE]Related articlesFree article

Telmisartan, ramipril, or both in patients at high risk for vascular events.

ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C.

N Engl J Med. 2008 Apr 10;358(15):1547-59. Epub 2008 Mar 31.PMID: 18378520 [PubMed - indexed for MEDLINE]Related articlesFree article

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsärinne K, Oto A, Parkhomenko A, Piegas LS, Svendsen TL, Teo KK, Yusuf S; ONTARGET investigators.

Lancet. 2008 Aug 16;372(9638):547-53.PMID: 18707986 [PubMed - indexed for MEDLINE]Related articles

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

[No authors listed]

Lancet. 2000 Jan 22;355(9200):253-9. Erratum in: Lancet 2000 Sep 2;356(9232):860. PMID: 10675071 [PubMed - indexed for MEDLINE]Related articles

Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study.

Mann JF, Yi QL, Sleight P, Dagenais GR, Gerstein HC, Lonn EM, Bosch J; HOPE Investigators.

Clin Nephrol. 2005 Mar;63(3):181-7.PMID: 15786818 [PubMed - indexed for MEDLINE]Related articles

The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.

Sumner G, Salehian O, Yi Q, Healey J, Mathew J, Al-Merri K, Al-Nemer K, Mann JF, Dagenais G, Lonn E; HOPE Investigators.

J Cardiovasc Electrophysiol. 2009 Jul;20(7):781-7. Epub 2009 Feb 27.PMID: 19298567 [PubMed - indexed for MEDLINE]Related articles

Ramipril: a review of its use in the prevention of cardiovascular outcomes.

Warner GT, Perry CM.

Drugs. 2002;62(9):1381-405. Review.PMID: 12076194 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.

Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, Drury PL, Esmatjes E, Hricik D, Parikh CR, Raz I, Vanhille P, Wiegmann TB, Wolfe BM, Locatelli F, Goldhaber SZ, Lewis EJ; Irbesartan Diabetic Nephropathy Trial. Collaborative Study Group.

Ann Intern Med. 2003 Apr 1;138(7):542-9.PMID: 12667024 [PubMed - indexed for MEDLINE]Related articlesFree article

The HOPE Study (Heart Outcomes Prevention Evaluation).

Sleight P.

J Renin Angiotensin Aldosterone Syst. 2000 Mar;1(1):18-20. Review.PMID: 11967789 [PubMed - indexed for MEDLINE]Related articles

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

Bakris GL, Weir MR.

Arch Intern Med. 2000 Mar 13;160(5):685-93.PMID: 10724055 [PubMed - indexed for MEDLINE]Related articlesFree article

Spotlight on ramipril in the prevention of cardiovascular outcomes.

Warner GT, Perry CM.

Am J Cardiovasc Drugs. 2003;3(2):113-6. Review.PMID: 14727938 [PubMed - indexed for MEDLINE]Related articles

Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency.

Tonelli M, Moyé L, Sacks FM, Kiberd B, Curhan G; Cholesterol and Recurrent Events (CARE) Trial Investigators.

Ann Intern Med. 2003 Jan 21;138(2):98-104.PMID: 12529091 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of long-term therapy with ramipril in high-risk women.

Lonn E, Roccaforte R, Yi Q, Dagenais G, Sleight P, Bosch J, Suhan P, Micks M, Probstfield J, Bernstein V, Yusuf S; HOPE Investigators. Heart Outcomes Prevention Evaluation.

J Am Coll Cardiol. 2002 Aug 21;40(4):693-702.PMID: 12204499 [PubMed - indexed for MEDLINE]Related articles